Viewing Study NCT03365505


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-09 @ 3:28 AM
Study NCT ID: NCT03365505
Status: UNKNOWN
Last Update Posted: 2017-12-07
First Post: 2017-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Frailty Assessment in Elderly Patients With Acute Coronary Syndrome
Sponsor: Meir Medical Center
Organization:

Study Overview

Official Title: Frailty Assessment in Elderly Patients With Acute Coronary Syndrome
Status: UNKNOWN
Status Verified Date: 2017-12
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Frailty is known as an independent risk factor for morbidity and mortality in older cardiac patients . It is an important factor on the cardiologist decision between conservative and invasive treatment in older patient with acute coronary syndrome, and is usually made subjectively by the cardiologist known in the literature as eyeball testing.

in this study the investigators will compare the cardiologists eye ball testing to objective frailty assessment based on Fried score and Edmonton frailty scale.
Detailed Description: elderly patients admitted to Meir hospital with acute coronary syndrome will be assessed for frailty twice: the first frailty assessment will be a subjective eye ball testing made by the cardiologist, the second assessment will be an objective one based on Fried frailty score and Edmonton frail scale.

The cardiologist will not be aware of the objective frailty assessment result.

The eye ball testing will be compared to the objective frailty assessment (Fried score and Edmonton frailty scale).

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: